Tidutamab (XmAb-18087) is a bispecific antibody (bsAb) that is both humanized and optimized for affinity, targeting the SSTR2 and CD3 domains to bind to the somatostatin receptor 2 (SSTR2) and T cells, respectively. It features a full Fc domain to ensure
CAS Number:
[2148354-90-7]
* VAT and and shipping costs not included. Errors and price changes excepted